A Plea for Long-Term Surveillance in Bacillus Calmette-Guerin-Treated Non-Muscle-Invasive Bladder Cancer

被引：2
|
作者：
Meijer, Richard P. [1 ]
van Rhijn, Bas W. G. [1 ]
机构：
[1] Antoni van Leeuwenhoek Hosp, Netherlands Canc Inst, Dept Urol, Div Surg Oncol, NL-1066 CX Amsterdam, Netherlands
来源：
EUROPEAN UROLOGY | 2012年 / 61卷 / 03期
关键词：
UROTHELIAL CARCINOMA; EPIDEMIOLOGY; METAANALYSIS; PROGRESSION; GUIDELINES; RISK;
D O I：
10.1016/j.eururo.2011.11.052
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：508 / 509
页数：2
相关论文
共 50 条
  • [1] Prognostic Factors Including Ki-67 and p53 in Bacillus Calmette-Guerin-Treated Non-Muscle-Invasive Bladder Cancer: A Prospective Study
    Oderda, Marco
    Ricceri, Fulvio
    Pisano, Francesca
    Fiorito, Chiara
    Gurioli, Alberto
    Casetta, Giovanni
    Zitella, Andrea
    Pacchioni, Donatella
    Gontero, Paolo
    UROLOGIA INTERNATIONALIS, 2013, 90 (02) : 184 - 190
  • [2] Intravesical Bacillus Calmette-Guerin with interferon-alpha versus intravesical Bacillus Calmette-Guerin for treating non-muscle-invasive bladder cancer
    Shepherd, Andrew R. H.
    Shepherd, Emily
    Brook, Nicholas R.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2017, (03):
  • [3] The Role of Bacillus Calmette-Guerin in the Treatment of Non-Muscle-Invasive Bladder Cancer
    Gontero, Paolo
    Bohle, Andreas
    Malmstrom, Per-Uno
    O'Donnell, Michael A.
    Oderda, Marco
    Sylvester, Richard
    Witjes, Fred
    EUROPEAN UROLOGY, 2010, 57 (03) : 410 - 429
  • [4] Prognostic significance of Bacillus Calmette-Guerin failure classification in non-muscle-invasive bladder cancer
    Shirakawa, Hiroshi
    Kikuchi, Eiji
    Tanaka, Nobuyuki
    Matsumoto, Kazuhiro
    Miyajima, Akira
    Nakamura, So
    Oya, Mototsugu
    BJU INTERNATIONAL, 2012, 110 (6B) : E216 - E221
  • [5] Tumor Multiplicity Is an Independent Prognostic Factor of Non-muscle-invasive Bladder Cancer Treated with Bacillus Calmette-Guerin Immunotherapy
    Ajili, Faouzia
    Manai, Mohamed
    Darouiche, Amine
    Chebil, Mohamed
    Boubaker, Samir
    ULTRASTRUCTURAL PATHOLOGY, 2012, 36 (05) : 320 - 324
  • [6] Emerging treatments for bacillus Calmette-Guerin-unresponsive non-muscle-invasive bladder cancer
    Kim, Hyung Suk
    Seo, Ho Kyung
    INVESTIGATIVE AND CLINICAL UROLOGY, 2021, 62 (04) : 361 - 377
  • [7] The Efficiency of the EORTC Scoring System for the Prediction of Recurrence and Progression of Non-muscle-invasive Bladder Cancer Treated by Bacillus Calmette-Guerin Immunotherapy
    Ajili, Faouzia
    Darouiche, Amine
    Chebil, Mouhamed
    Boubaker, Samir
    ULTRASTRUCTURAL PATHOLOGY, 2013, 37 (04) : 249 - 253
  • [8] Intravesical bacillus Calmette-Guerin instillation in non-muscle-invasive bladder cancer: A review
    Saluja, Manmeet
    Gilling, Peter
    INTERNATIONAL JOURNAL OF UROLOGY, 2018, 25 (01) : 18 - 24
  • [9] Somatic Features of Response and Relapse in Non-muscle-invasive Bladder Cancer Treated with Bacillus Calmette-Guerin Immunotherapy
    Bacon, Jack V. W.
    Muller, David C.
    Ritch, Elie
    Annala, Matti
    Dugas, Sarah G.
    Herberts, Cameron
    Vandekerkhove, Gillian
    Seifert, Helge
    Zellweger, Tobias
    Black, Peter C.
    Bubendorf, Lukas
    Wyatt, Alexander W.
    Rentsch, Cyrill A.
    EUROPEAN UROLOGY ONCOLOGY, 2022, 5 (06): : 677 - 686
  • [10] Estimated Costs and Long-term Outcomes of Patients With High-Risk Non-Muscle-Invasive Bladder Cancer Treated With Bacillus Calmette-Guerin in the Veterans Affairs Health System
    Williams, Stephen B.
    Howard, Lauren E.
    Foster, Meagan L.
    Klaassen, Zachary
    Sieluk, Jan
    De Hoedt, Amanda M.
    Freedland, Stephen J.
    JAMA NETWORK OPEN, 2021, 4 (03)
12345